메타바이오메드

059210KOSDAQ의료용품 및 기타 의약 관련제품 제조업

67.5 / 100

Reference Date: 2026-06-10

Financial Score33.0 / 40

News Sentiment17.5 / 25

Momentum3.0 / 20

Disclosure14.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Plunged 15.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

MetaBioMed is a company specializing in the production and sale of medical devices and materials, including dental supplies, absorbable synthetic sutures, and cosmetic materials. The company focuses on dental nerve treatment materials and synthetic sutures, with growing demand for synthetic sutures replacing traditional animal-based products and sustained growth in the dental materials market.

Number of Employees

345people

Average Salary

52.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

8.08Industry Average 19.198.0Point

Half of industry avg (excellent)

PBR

0.77Industry Average 1.305.5Point

Lower than industry avg (good)

ROE

9.75Industry Average -4.893.5Point

Well below industry avg

Debt Ratio

1.68Industry Average 6.868.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲11.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲42.3% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 16.9% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 1Negative 0Average Sentiment Score 70

Neutral
충북도, '첨단소재 AX 플랫폼' 공모 선정…국비 146억 확보
지방정부의 첨단소재 관련 공모 선정으로 인한 예산 확보 소식이지만, 메타바이오메드(059210)에 직접적인 영향은 제한적입니다.
Positive
[클릭 e종목]"메타바이오메드, 필러·스킨부스터 성장성 주목…2027년...
NH투자증권의 분석에 따르면 메타바이오메드의 PDO 기반 의료미용 제품 확장이 중장기 성장 잠재력을 높이고 있다.
Positive
메타바이오메드, 30억원 규모 자사주 취득 결정
메타바이오메드의 자사주 취득 결정으로 주주가치 제고와 직원 보상 강화 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 3,540Won52-week high 6,52052-week low 3,540

1-month return0.0Point

1m -15.81% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

7 totalPositive 2Neutral 5Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-04
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-22
Neutral분기보고서 (2026.03)2026-05-15
Neutral[기재정정]분기보고서 (2026.03)2026-05-15
Positive주요사항보고서(자기주식취득결정)2026-05-14